Table of Content

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of The World

3. Market Determinant
3.1. Market Motivators
3.2. Restraints
3.3. Opportunities

4. Market Segmentation
4.1. Global Brain and Spinal Cord Cancer Market on the Basis of Type
4.1.1. Grade I
4.1.2. Grade Ii
4.1.3. Grade Iii
4.1.4. Grade Iv
4.2. Global Brain and Spinal Cord Cancer Market on the Basis of Diagnostic Test
4.2.1. Imaging Tests
4.2.2. Magnetic Resonance Imaging (MRI) Scan
4.2.3. Computed Tomography (CT) Scan
4.2.4. Positron Emission Tomography (Pet) Scan
4.2.5. Chest X-Ray
4.3. Global Brain and Spinal Cord Cancer Market on the Basis of Treatment
4.3.1. Surgery
4.3.2. Chemotherapy
4.3.3. Radiation Therapy
4.3.4. Targeted Therapy
4.3.5. Alternating Electric Field Therapy
4.3.6. Other

5. Competitive Landscape
5.1. Market Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia Pacific
6.4. Rest of The World

7. Company Profiles
7.1. Actinium Pharmaceuticals Inc.
7.2. Affichem
7.3. Biogen Idec Inc.
7.4. Bristol-Myers Squibb
7.5. Daiichi Sankyo
7.6. Eli Lilly And Co.
7.7. Ge Healthcare
7.8. Genzyme Corp.
7.9. Merck & Co., Inc.
7.10. Ono Pharmaceutical Co.
7.11. Genzyme Corp.
7.12. GlaxoSmithKline Plc.
7.13. Pfizer Inc.
7.14. Roche Holding AG
7.15. Spectrum Pharmaceuticals Inc.
7.16. Sunesis Pharmaceuticals Inc.
7.17. Takeda Oncology
7.18. Teva Pharmaceuticals



List of Figures


FIGURE # 1 GLOBAL BRAIN AND SPINAL CORD CANCER MARKET SHARE ON BASIS OF TYPE, 2017 VS 2023 (%)
FIGURE # 2 GLOBAL BRAIN AND SPINAL CORD CANCER MARKET SHARE ON THE BASIS OF DIAGNOSTIC, 2017 VS 2023 (%)
FIGURE # 3 GLOBAL BRAIN AND SPINAL CORD CANCER MARKET SHARE ON THE BASIS OF TREATMENT, 2017 VS 2023 (%)
FIGURE # 4 NORTH AMERICA BRAIN AND SPINAL CORD CANCER MARKET SHARE, 2017 VS 2023 (%)
FIGURE # 5 US BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 CANADA BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 EUROPEAN BRAIN AND SPINAL CORD CANCER MARKET SHARE, 2017 VS 2023 (%)
FIGURE # 8 UK BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 FRANCE BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 GERMANY BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 ITALY BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 SPAIN BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 ROE BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 ASIA PACIFIC BRAIN AND SPINAL CORD CANCER MARKET SHARE, 2017 VS 2023 (%)
FIGURE # 15 INDIA BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 CHINA BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 JAPAN BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 18 ROAPAC BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 19 REST OF THE WORLD BRAIN AND SPINAL CORD CANCER MARKET SIZE, 2017-2023 ($ MILLION)

 

List of Tables


TABLE # 1 GLOBAL BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS) ON BASIS OF TYPE, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL GRADE I MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL GRADE II MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL GRADE III MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL GRADE IV MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS ON THE BASIS OF DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL IMAGING TESTS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL MAGNETIC RESONANCE IMAGING (MRI) SCAN MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL COMPUTED TOMOGRAPHY (CT) SCAN MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCAN MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL CHEST X-RAY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS ON THE BASIS OF TREATMENT, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL RADIATION THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL TARGETED THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 16 GLOBAL ALTERNATING ELECTRIC FIELD THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 17 GLOBAL OTHER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 18 NORTH AMERICAN BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS, BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 19 NORTH AMERICAN BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS, ON BASIS OF TYPE, 2017-2023 ($ MILLION)
TABLE # 20 NORTH AMERICAN BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS, ON THE BASIS OF DIAGNOSTIC, 2017-2023 ($ MILLION)
TABLE # 21 NORTH AMERICAN BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS, ON THE BASIS OF TREATMENT, 2017-2023 ($ MILLION)
TABLE # 22 EUROPEAN BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS, BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 23 EUROPEAN BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS, ON BASIS OF TYPE, 2017-2023 ($ MILLION)
TABLE # 24 EUROPEAN BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS, ON THE BASIS OF DIAGNOSTIC, 2017-2023 ($ MILLION)
TABLE # 25 EUROPEAN BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS, ON THE BASIS OF TREATMENT, 2017-2023 ($ MILLION)
TABLE # 26 APAC BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023, ($ MILLION)
TABLE # 27 APAC BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS, ON BASIS OF TYPE, 2017-2023 ($ MILLION)
TABLE # 28 APAC BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS ON THE BASIS OF DIAGNOSTIC, 2017-2023, ($ MILLION)
TABLE # 29 APAC BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS ON THE BASIS OF TREATMENT, 2017-2023, ($ MILLION)
TABLE # 30 ROW BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS, ON BASIS OF TYPE, 2017-2023 ($ MILLION)
TABLE # 31 ROW BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS ON THE BASIS OF DIAGNOSTIC, 2017-2023 ($ MILLION)
TABLE # 32 ROW BRAIN AND SPINAL CORD CANCER MARKET RESEARCH AND ANALYSIS ON THE BASIS OF TREATMENT, 2017-2023 ($ MILLION)